HOME >> BIOLOGY >> NEWS
Signal for inflammation linked to Ras-induced tumor growth

Cancer progression is dependent on the ability of tumor cells to interact with and favorably influence their environment. For instance, if a tumor is going expand, it is absolutely critical that new blood vessels are formed so that an adequate blood supply is in place to feed the growing tissue. A new research study published in the November issue of Cancer Cell demonstrates that a cytokine, a chemical signal that stimulates inflammation, plays a critical role in the initiation of new vasculature formation required to promote tumor progression.

Previous research has suggested that there may be a link between cancer-associated angiogenesis and inflammation. The protooncogene Ras has also been implicated in tumor-driven blood vessel generation. Ras is abnormally activated in nearly one quarter of all human cancers and is involved in many aspects of tumor progression, including interactions between tumor cells and the surrounding environment. However, the mechanisms that underlie these interactions are unclear.

Dr. Dafna Bar-Sagi from the Department of Molecular Genetics and Microbiology at the State University of New York at Stony Brook examined whether Ras-mediated induction of the inflammatory mediator CXCL-8 was required for tumor growth and angiogenesis in a mouse model. The researchers found that CXCL-8 production was required for Ras-stimulated tumor inflammation, vascularization, and growth. In addition, inhibition of CXCL-8 function in tumors expressing Ras led to a marked decrease in tumor angiogenesis.

Molecules that modulate CXCL-8 expression are known targets of the Ras signaling pathway, establishing a physiological link between these signaling molecules. The researchers conclude that in response to Ras activation, proinflammatory cytokines such as CXCL-8 may recruit immune cells and endothelial cells to tumor sites, representing a new mechanism for cancer-driven blood vessel generation. According to Dr. Bar-Sagi, "Our findin
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
15-Nov-2004


Page: 1 2

Related biology news :

1. Signaling for cartilage
2. Funnel in the eye: Signal focusing increases photosensitivity
3. Signaling proteins may represent biomarkers for melanoma
4. Signaling protein builds bigger, better bones in mice
5. Penn researchers discover how key protein stops inflammation
6. Gene variations directly link inflammation to an increased risk for lung cancer
7. p53 gene mutations and inflammation trigger skin cancer
8. Remicade data in ankylosing spondylitis show improvement in spinal mobility and spinal inflammation
9. Hot on the TRAIL of controlling inflammation in bacterial meningitis
10. NIAID supports research into etiology of fungal-induced inflammation in chronic sinusitis
11. Omega-3 fatty acids affect risk of depression, inflammation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 06, 2020 , ... ... in the prestigious National STEM Scholar Program, a unique professional development program that ... project support for middle school science teachers nationwide. , Created in partnership between ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... therapeutics product portfolio with a near term focus on Type 2 diabetes and ... commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin ...
(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... , ... August 11, 2020 , ... ... year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network ... and 2022. The network is a consortium of academic research centers in the ...
(Date:8/3/2020)... ... 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company ... Known as MediVet Biologics since its formation in 2016, the company is relaunching ... Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... SOMERSET, N.J (PRWEB) , ... July 29, 2020 ... ... editing company, and Catalent, the leading global provider of advanced delivery technologies, development, ... products, today announced that they have entered into a strategic partnership whereby Catalent ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, ... surgery is only the beginning of a successful study, while protecting and accessing the ... Gien, Global Head of Surgery from Envigo in a live webinar ...
Breaking Biology Technology:
Cached News: